Rapidly progressive glomerulonephritis historical perspective
Rapidly progressive glomerulonephritis Microchapters |
Differentiating Rapidly progressive glomerulonephritis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Rapidly progressive glomerulonephritis historical perspective On the Web |
American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis historical perspective |
FDA on Rapidly progressive glomerulonephritis historical perspective |
CDC on Rapidly progressive glomerulonephritis historical perspective |
Rapidly progressive glomerulonephritis historical perspective in the news |
Blogs on Rapidly progressive glomerulonephritis historical perspective |
Directions to Hospitals Treating Rapidly progressive glomerulonephritis |
Risk calculators and risk factors for Rapidly progressive glomerulonephritis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
RPGN was discovered in 1958 by Australians Stanton and Tait.
Historical perspective
- Ernst Goodpasture made case reports about glomerulnophritis and pulmonary haemorrhages in 1919[1].
- Stanton and Tait from Australia studied these case reports and then named the findings as Goodpasture syndrome. in 1958.
- They gave the anti GBM antibodies classification and discovered RPGN in these cases.
- In 1960s, electron microscopy and immunofluorescence helped learn RPNG on immunological level.
References
- ↑ McAdoo SP, Pusey CD (2017). "Anti-Glomerular Basement Membrane Disease". Clin J Am Soc Nephrol. 12 (7): 1162–1172. doi:10.2215/CJN.01380217. PMC 5498345. PMID 28515156.